Journal of Microbiology, Immunology and Infection The epidemiology, antibiograms and predictors of mortality among critically-ill patients with central line-associated bloodstream infections Shin-Huei Kuo, Wei-Ru Lin, Jun-You Lin, Chung-Hao Huang, Ya-Ting Jao, Pei-Wen Yang, Jong-Rung Tsai, Wen-Hung Wang, Yen-Hsu Chen, Ching-Tzu Hung, Po-Liang Lu Journal of Microbiology, Immunology and Infection DOI: 10.1016/j.jmii.2017.08.016 Copyright © 2017 Terms and Conditions
Figure 1 The secular trend of total CLABSI incidence in our adult ICUs (Arrow: the year of central line care bundle implementation; black arrow). CLABSI = central line-associated bloodstream infections, ICU = intensive care unit. Journal of Microbiology, Immunology and Infection DOI: (10.1016/j.jmii.2017.08.016) Copyright © 2017 Terms and Conditions
Figure 2 Annual incidence of CLABSI (per 1000 catheter-days) in different MDROs and Candida in our hospital (Arrow: the year of central line care bundle implementation). VRE = vancomycin-resistant Enterococcus faecium. MRSA = methicillin-resistant Staphylococcus aureus. CRAB = carbapenem-resistant Acinetobacter baumannii. CRPA = carbapenem-resistant Pseudomonas aeruginosa. CREn = carbapenem-resistant Enterobacteriaceae. CLABSI = central line-associated bloodstream infections, MDROs = multidrug-resistant organisms. Journal of Microbiology, Immunology and Infection DOI: (10.1016/j.jmii.2017.08.016) Copyright © 2017 Terms and Conditions